StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
UPDATE: Amgen (AMGN) Wins FDA Panel Backing for Repatha
June 10, 2015 3:57 PM
(Updated - June 10, 2015 4:26 PM EDT)An FDA panel voted 11-4 to back ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Corporate News
FDA
Hot FDA News
Next Articles
FDA Panel Points to Narrower Label for Amgen's (AMGN) Repatha, Nomura Notes
June 11, 2015 8:31 AM
Cowen Maintains Bullish View on Amgen (AMGN) Following Panel Repatha In Familial Hypercholesterolemia
June 11, 2015 7:13 AM
Amgen (AMGN) Bullish Stance Reiterated at Jefferies Following Repatha Panel Backing
June 11, 2015 6:43 AM